Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to evaluate the efficacy and safety of dronabinol in
trichotillomania and other body-focused repetitive behaviors such as skin-picking disorder.
50 subjects with DSM-5 trichotillomania or skin-picking disorder will receive 10 weeks of
double-blind dronabinol or placebo. The hypothesis to be tested is that dronabinol will be
effective and well tolerated in patients with trichotillomania and/or skin-picking disorder
compared to placebo. The proposed study will provide needed data on the treatment of
disabling disorders that currently lacks a clearly effective treatment.